Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4856175
Max Phase: Preclinical
Molecular Formula: C23H31N3O3S
Molecular Weight: 429.59
Molecule Type: Unknown
Associated Items:
ID: ALA4856175
Max Phase: Preclinical
Molecular Formula: C23H31N3O3S
Molecular Weight: 429.59
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COc1ccccc1N1CCN([C@H]2CCCC[C@@H]2NS(=O)(=O)c2ccccc2)CC1
Standard InChI: InChI=1S/C23H31N3O3S/c1-29-23-14-8-7-13-22(23)26-17-15-25(16-18-26)21-12-6-5-11-20(21)24-30(27,28)19-9-3-2-4-10-19/h2-4,7-10,13-14,20-21,24H,5-6,11-12,15-18H2,1H3/t20-,21-/m0/s1
Standard InChI Key: OVTXOMMQHRIKGL-SFTDATJTSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 429.59 | Molecular Weight (Monoisotopic): 429.2086 | AlogP: 3.11 | #Rotatable Bonds: 6 |
Polar Surface Area: 61.88 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.17 | CX Basic pKa: 7.04 | CX LogP: 3.82 | CX LogD: 3.66 |
Aromatic Rings: 2 | Heavy Atoms: 30 | QED Weighted: 0.76 | Np Likeness Score: -1.10 |
1. Leser C, Keller M, Gerndt S, Urban N, Chen CC, Schaefer M, Grimm C, Bracher F.. (2021) Chemical and pharmacological characterization of the TRPML calcium channel blockers ML-SI1 and ML-SI3., 210 [PMID:33187805] [10.1016/j.ejmech.2020.112966] |
2. Leser C, Keller M, Gerndt S, Urban N, Chen CC, Schaefer M, Grimm C, Bracher F.. (2021) Chemical and pharmacological characterization of the TRPML calcium channel blockers ML-SI1 and ML-SI3., 210 [PMID:33187805] [10.1016/j.ejmech.2020.112966] |
Source(1):